Reduction in Peripheral CD19+ CD27- Naive B Cells Is Associated with Clinical Remission in Patients with Rheumatoid Arthritis Receiving Combined Treatment with Methotrexate and TNF Inhibitors

被引：0
|
作者：
Hernandez-Breijo, Borja [1 ]
Plasencia, Chamaida [2 ]
Navarro-Compan, Victoria [3 ]
Nieto-Ganan, Israel [4 ]
Sobrino, Cristina [5 ]
Martinez-Feito, Ana [3 ]
Garcia-Hoz, Carlota [4 ]
Lapuente-Suanzes, Paloma [4 ]
Bachiller-Corral, Javier [6 ]
Bonilla, Gema [2 ]
Pijoan-Moratalla, Cristina [6 ]
Roy, Garbine [4 ]
Vazquez, Monica [6 ]
Balsa, Alejandro [2 ]
Villar, Luisa M. [4 ]
Pascual-Salcedo, Dora [3 ]
Rodriguez-Martin, Eulalia [4 ]
机构：
[1] La Paz Univ Hosp, IdiPAZ, Immunorheumatol Res Grp, Madrid, Spain
[2] La Paz Univ Hosp, IdiPAZ, Rheumatol, Madrid, Spain
[3] Hosp Univ La Paz, IdiPaz, Madrid, Pais Vasco, Spain
[4] Hosp Univ Ramon & Cajal, IRYCIS, Madrid, Spain
[5] Hosp Ramon & Cajal, IRYCIS, Madrid, Spain
[6] Hosp Univ Ramon & Cajal, Rheumatol, Madrid, Spain
来源：
ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1227
引用
收藏
页数：3
相关论文
共 26 条
  • [1] Remission Induced by TNF Inhibitors Plus Methotrexate is Associated With Changes in Peripheral Naive B Cells in Patients With Rheumatoid Arthritis
    Hernandez-Breijo, Borja
    Plasencia-Rodriguez, Chamaida
    Navarro-Compan, Victoria
    Garcia-Hoz, Carlota
    Nieto-Ganan, Israel
    Sobrino, Cristina
    Bachiller-Corral, Javier
    Diaz-Almiron, Mariana
    Martinez-Feito, Ana
    Jurado, Teresa
    Lapuente-Suanzes, Paloma
    Bonilla, Gema
    Pijoan-Moratalla, Cristina
    Roy, Garbine
    Vazquez-Diaz, Monica
    Balsa, Alejandro
    Villar, Luisa M.
    Pascual-Salcedo, Dora
    Rodriguez-Martin, Eulalia
    FRONTIERS IN MEDICINE, 2021, 8
  • [2] Citrullinated peptide-specific CD19+ B cells are present in synovial tissue and peripheral blood of patients with rheumatoid arthritis
    Ruzickova, S.
    Cimburek, Z.
    Moravcova, T.
    Huzlova, Z.
    Vesela, I.
    Niederlova, J.
    Krystufkova, O.
    Vencovsky, J.
    ARTHRITIS RESEARCH & THERAPY, 2005, 7 (Suppl 1) : S53 - S53
  • [3] Changes in CD4+T and B Cell Profile As Indicator of Clinical Remission to TNF Inhibitors in Patients with Rheumatoid Arthritis
    Hernandez-Breijo, Borja
    Ganan-Nieto, Israel
    Sobrino, Cristina
    Navarro-Compan, Victoria
    Martinez, Ana
    Garcia-Hoz, Carlota
    Bachiller, Javier
    Bonilla Hernan, Maria Gema
    Roy, Garbine
    Vazquez, Monica
    Balsa, Alejandro
    Maria Villar, Luisa
    Pascual-Salcedo, Dora
    Rodriguez-Martin, Eulalia
    Plasencia, Chamaida
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [4] TNF blockade results in an increase of CD20+CD27+(memory) B cells in the peripheral circulation of rheumatoid arthritis (RA) patients.
    Goldbach-Mansky, RT
    Souto-Carneiro, MM
    Mahadevan, V
    Ettinger, R
    Carrero, H
    Wilson, M
    Lipsky, PE
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S505 - S505
  • [5] Enrichment of differentiated CD45RB(dim),CD27- memory T cells in the peripheral blood, synovial fluid, and synovial tissue of patients with rheumatoid arthritis
    Kohem, CL
    Brezinschek, RI
    Wisbey, H
    Tortorella, C
    Lipsky, PE
    OppenheimerMarks, N
    ARTHRITIS AND RHEUMATISM, 1996, 39 (05): : 844 - 854
  • [6] B-CELL PHENOTYPE AND IGD-CD27-MEMORY B CELLS ARE AFFECTED BY TNF-INHIBITORS AND TOCILIZUMAB TREATMENT IN RHEUMATOID ARTHRITIS
    Moura, Rita A.
    Quaresma, Claudia
    Vieira, Ana R.
    Goncalves, Maria J.
    Polido-Pereira, Joaquim
    Romao, Vasco C.
    Martins, Nadia
    Canhao, Helena
    Fonseca, Joao E.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : A3 - A3
  • [7] B-cell phenotype and IgD-CD27-memory B cells are affected by TNF-inhibitors and tocilizumab treatment in rheumatoid arthritis
    Moura, Rita A.
    Quaresma, Claudia
    Vieira, Ana R.
    Goncalves, Maria J.
    Polido-Pereira, Joaquim
    Romao, Vasco C.
    Martins, Nadia
    Canhao, Helena
    Fonseca, Joao E.
    PLOS ONE, 2017, 12 (09):
  • [8] B-CELL PHENOTYPE AND IGD-CD27-MEMORY B CELLS ARE AFFECTED BY TNF-INHIBITORS AND TOCILIZUMAB TREATMENT IN RHEUMATOID ARTHRITIS
    Moura, R. A.
    Quaresma, C.
    Vieira, A. R.
    Goncalves, M. J.
    Polido-Pereira, J.
    Romao, V. C.
    Martins, N.
    Canhao, H.
    Fonesca, J. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 834 - 834
  • [9] GM-CSF PRODUCED BY CD4+T CELLS AS A MARKER OF CLINICAL REMISSION IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TNF INHIBITORS
    Hernandez-Breijo, B.
    Plasencia, C.
    Garcia-Hoz, C.
    Sobrino, C.
    Navarro-Compan, V.
    Martinez-Feito, A.
    Nieto-Ganan, I.
    Lapuente-Suanzes, P.
    Bachiller-Corral, J.
    Bonilla, G.
    Pijoan Moratalla, C.
    Roy, G.
    Vazquez Diaz, M.
    Balsa, A.
    Villar, L. M.
    Pascual-Salcedo, D.
    Rodriguez-Martin, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 891 - 891
  • [10] Possible Recruitment of Peripheral Blood CXCR3+ CD27+ CD19+ B Cells to the Liver of Chronic Hepatitis C Patients
    Mizuochi, Toshiaki
    Ito, Masahiko
    Saito, Koji
    Kasai, Michiyuki
    Kunimura, Toshiaki
    Morohoshi, Toshio
    Momose, Haruka
    Hamaguchi, Isao
    Takai, Kenji
    Iino, Shiro
    Suzuki, Miho
    Mochida, Satoshi
    Ikebuchi, Kenji
    Yamaguchi, Kazunari
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2010, 30 (04): : 243 - 251
123